PID Treatment in Nepal — Pelvic Inflammatory Disease Symptoms, the Infection Link, Early Treatment & Protecting Fertility

What PID Is and Why Timing Matters

Pelvic inflammatory disease is infection and inflammation of upper genital tract in women — uterus, fallopian tubes and ovaries. It is usually caused by an ascending STI — chlamydia or gonorrhea traveling upward from cervix — though other infections contribute. Roughly 10–15% of untreated chlamydia progresses to PID.

The reason PID is treated as urgent is its consequences: tubal scarring causes infertility, ectopic pregnancy risk rises substantially, and chronic pelvic pain can persist long after infection clears. Each episode of PID increases chance of these outcomes — early, adequate treatment is difference between a treated infection and permanent damage.

Symptoms range from obvious (fever, significant lower abdominal pain, abnormal discharge, pain with sex) to subtle (vague pelvic discomfort, irregular bleeding, pain during examination). Because damage is quiet, low-threshold assessment matters: if picture could be PID, early empiric treatment is safer than watching.

Symptoms & When to Suspect PID

Classically: lower abdominal or pelvic pain, abnormal vaginal discharge, fever, pain with deep intercourse, and irregular bleeding (including bleeding after sex or between periods). On examination, cervical motion tenderness — pain when cervix is moved — is characteristic sign.

The subtler version is more common than textbook one: vague lower-pelvic discomfort, mild discharge change, or discomfort with intercourse in a woman with a risk exposure. Because cost of missing PID is high and cost of empiric treatment is low, threshold for treating is deliberately low.

How PID Is Diagnosed

PID is primarily a clinical diagnosis — combination of symptoms, examination findings (cervical motion tenderness, adnexal tenderness), and risk context. There is no single definitive test; waiting for perfect confirmation before treating loses window in which treatment prevents damage.

Testing supports diagnosis and finds cause: NAAT for chlamydia and gonorrhea, pregnancy test (ectopic is critical differential), inflammatory markers, and ultrasound where complications (tubo-ovarian abscess) or alternative diagnoses are suspected. A negative STI screen does not exclude PID — other organisms and recently cleared infection still produce it.

Treatment

Treatment is broad-spectrum antibiotics covering chlamydia, gonorrhea and other organisms that cause PID — started empirically when PID is plausible, not after days of waiting for confirmation. Outpatient treatment works for most cases; severe cases — high fever, abscess, inability to tolerate oral medication, or pregnancy — need hospital-level care.

Partner management is essential: partners should be tested and usually treated even without symptoms — an untreated partner reinfects. During treatment and until partner treatment is complete, abstain from sex. Follow-up confirms response and need for any repeat testing.

Consequences & Prevention

Each PID episode raises chance of tubal infertility (roughly ~10–20% after one episode, higher after repeated episodes), ectopic pregnancy risk increases several-fold, and chronic pelvic pain affects a significant minority long-term. These are not rare outcomes — they are natural history of untreated or late-treated infection.

Prevention is upstream: consistent barrier use, treatment of any diagnosed chlamydia or gonorrhea before it ascends, screening after risk (because source infections are often silent), and partner treatment whenever an STI is diagnosed. A PID episode is also a marker for broader screening — it signals exposure to organisms that need detection in both partners.

PID Services & Costs

Transparent pricing; confirm when booking.

Related Services & Guides